What is Veracyte's remainder of 2026?

Veracyte (VCYT) reported remainder of 2026 of $9.39M in Q1 2026.

How has Veracyte's remainder of 2026 changed year-over-year?

Veracyte's remainder of 2026 decreased by 2.4% year-over-year, from $9.62M to $9.39M.

Veracyte VCYT Remainder of 2026

Remainder of 2026 at other companies

Guardant HealthGH

——

Natera, Inc.NTRA

——

RevvityRVTY

——

Agilent TechnologiesA

——

AbbottABT

——

Lantheus HoldingsLNTH

——

Other financials

Income statement

See full

Revenue$139.1M+21.5%

Gross profit$101.2M+27.2%

Operating income$22.6M+680%

Net income$28.7M+307%

EPS (diluted)$0.35+289%

Balance sheet

See full

Cash & equivalents$264.8M+41.0%

Total debt$39.3M-22.1%

Total equity$1.3B+12.5%

Total assets$1.4B+9.2%

Cash flow

See full

Operating cash flow$35.2M+557%

CapEx$3.0M+62.8%

Free cash flow$32.3M+810%

Valuation

See full

Market cap$4.29B+10.7%

Profitability

See full

Gross margin70.9%+2.9pp

Operating margin14.3%+9.2pp

Net margin16.2%+9.1pp

FCF margin28.7%+11.7pp

Returns & leverage

See full

Return on equity6.9%+4.1pp

Debt / equity0×0.0×

Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's remainder of 2026.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Veracyte's remainder of 2026?: Veracyte (VCYT) reported remainder of 2026 of $9.39M in Q1 2026.
How has Veracyte's remainder of 2026 changed year-over-year?: Veracyte's remainder of 2026 decreased by 2.4% year-over-year, from $9.62M to $9.39M.